FDA: Many CBD products contain far less, sometimes more, than advertised

​By Ivan Moreno, HempIndustryDaily.com

Testing of CBD-infused products conducted by the U.S. Food and Drug Administration found that many are mislabeled, containing far less or more CBD than advertised and in some instances THC that wasn’t supposed to be there.

Of the 102 products tested this year that were labeled as having CBD, 18 had less than 80% of the amount indicated, while another 46 were within 20% of the amount advertised. Thirty-eight products had more than 120% of the CBD indicated.

The results were included in an undated letter to Congress that Hemp Industry Daily obtained Wednesday. An FDA spokesman confirmed the letter but declined to comment on the findings.

In all, the FDA tested 147 products. Not all were labeled as having CBD, but 138 contained at least some amount of the cannabinoid. Of the 147 products, 72 contained some THC, although the concentrations were low.
The testing included:

• tinctures.
• oils.
• capsules.
• edibles.
• drinks.
• pet products.

The products were chosen at random after the FDA searched the internet for products. The agency also chose products from:

• firms that have previously received FDA warning letters for making health claims about CBD.
• industry event participants.
• advertisers in trade journals.

The federal agency repeatedly noted that the testing was from a limited sample size and that no definitive conclusions could be drawn, but “supports the need for” long-term study.
The FDA said in its letter that it “recognizes the significant public interest in CBD products.”

“However, there are many questions about the characteristics of currently marketed CBD products.”

Read more...

​

---